News Digest / Ticker: COCH

Ticker: COCH

09:04am, Thursday, Jul 31, 2025

Envoy Medical Reports Growth in Revenues Amid Rising Losses and Ongoing FDA Approval Process

Envoy Medical, Inc. (NASDAQ: COCH) has recently released its quarterly report for the period ending June 30, 2025. The company is focused on innovative medical technologies, particularly in the hearing loss sector and is currently developing its flagship product, the Acclaim® cochlear implant. Ke...

05:14pm, Thursday, May 01, 2025

Envoy Medical Faces Financial Challenges Despite Strategic Developments in Hearing Tech Sector